Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts

E-ISSN： 1477-2574|17|8|707-712

ISSN： 1365-182x

Source： HPB, Vol.17, Iss.8, 2015-08, pp. : 707-712

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Good clinical outcomes following transjugular intrahepatic portosystemic stent‐shunts in Budd–Chiari syndrome

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 39, Iss. 8, 2014-04 ,pp. : 864-872

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. : 330-341

Karger

Access to resources Recommend Favorite

Intrahepatic shunt & refractory ascites

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 389-395

John Wiley & Sons Inc

Access to resources Recommend Favorite

The use of transjugular intrahepatic portosystemic shunt should be cautious in patients without cirrhosis with obliterative portal vein thrombosis

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1374-1375

John Wiley & Sons Inc

Access to resources Recommend Favorite

DEB‐TACE vs cTACE for inoperable HCC

HEPATOLOGY RESEARCH, Vol. 45, Iss. 2, 2015-01 ,pp. : 190-200

John Wiley & Sons Inc

Access to resources Recommend Favorite